Skip to main content
SpringerLink
Log in

Montelukast — evaluation in 6 to 14 years old children with persistent asthma — pediatric montelukast study group

  • Special Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective : The suffering of children with asthma as a persistent illness is present in approximately 10% of the total population. The prevalent treatment regimens available has been the inhaled coticosteroids and short acting bronchodialators. Though the therapies are rational and well accepted but at the cost of side effects on chronic use. The changing definitions and guidelines with regard to asthma have given a classified slot to newer treatments like leukotriene receptor antagonists (LTRAs). The aim of the present study was to study the efficacy and tolerability of montelukast in the treatment of Indian pediatric patients aged 6 to 14 years with chronic asthma.Methods: It was a prospective, open, non-comparative multicentric study. 881 Children (Mean age 11.83± 3.12 years) were included. Patients fulfilling the inclusion criteria were given one mouth dissolving 5 mg montelukast tablet daily in the evening for 30 days.Results : There was an overall improvement in all the efficacy parameters. The daytime total asthma score decreased from 9.55 ± 1.52 to 3.59 ±2.10. The average number of asthma attacks over the last 4 weeks decreased from 1.14± 1.19 to 0.28±0.57. The number of nocturnal awakenings fell from 1.54±0.78 to 0.43±0.54. FEV, (L) (Predicted J improved by 21.18%). PEFR (LJmin.) improved by 34.69%). Approximately 45% physicians rated the treatment as excellent, 30% as very good, 18% as good, 7% as fair and none as poor.Conclusion: Montelukast administered once daily improved efficacy end-points and was well tolerated in pediatric patients with chronic persistent asthma establishing itself as a valuable treatment option to current asthma therapies in 6 to 14 years old patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Guidelines for the Diagnosis and management of Asthma: Expert Panel Report 2. NIH Publication No. 97-4051; National Institutes of Health, National Heart, Lung and Blood Institute: Bethesda, MD, 1997.

    Google Scholar 

  2. Li JT, Pearlman DS, Nicklas RAet al. Alogarithm for the diagnosis and management of asthma: A practice parameter update.Ann Allergy Asthma Imp inol 1998; 81(5): 415–420.

    CAS  Google Scholar 

  3. Lipworth BJ. Systemic Adverse Effects of inhaled corticosteroid therapy: A systemic review and meta-analysis.Arc Intern Med 1999; 159(9): 941–955.

    Article  CAS  Google Scholar 

  4. Agertoft L. Effect of long term treatment with inhaled budesonide on adult height in children with asthma.N Engl J Med 2000; 343(15): 1054–1063.

    Article  Google Scholar 

  5. Garbe E, LeLorier J, Boivin JFet al. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or openangle glaucoma.JAMA 1997; 277(9): 722–727.

    Article  PubMed  CAS  Google Scholar 

  6. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients’ compliance with prescribed oral and inhaled asthma medications.Arch Intern Med 1994; 154(12): 1349–1352.

    Article  PubMed  CAS  Google Scholar 

  7. Busse WW. The role of leukotrienes in asthma and allergic rhinitis.Clin Exp Allergy 1996; 26: 868–879.

    Article  PubMed  CAS  Google Scholar 

  8. Drazen JM, Israel E, O’Bryne PM. Treatment of asthma with drugs modifying the leukotriene pathway.N Eng J Med 1999; 340: 197–206.

    Article  CAS  Google Scholar 

  9. Dworski R, FitzGerald GA, Oates JAet al. Effect of oral prednisilone on airway inflammatory mediators in atopic asthma.Am J Respir Crit Care Med 1994; 149: 953–959.

    PubMed  CAS  Google Scholar 

  10. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report (revised), 1998.

  11. Lofdhal CG, Reiss TF, Leff JAet al. Randomized placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients.BMJ 1999; 319(7202): 87–90.

    Google Scholar 

  12. Laviolette M, Malmstrom K, Lu Set al. Montelukast added to inhaled beclomethasone in treatment of asthma.Am J Respir Care Med 1999; 160(6): 1862–1868.

    CAS  Google Scholar 

  13. Reiss TF, Chervinsky P, Dockhorn RJet al. Montelukast, a once daily leukotriene receptor antagonist, in the treatment of chronic asthma.Arch Intern Med 1998; 158: 1213–1220.

    Article  PubMed  CAS  Google Scholar 

  14. Knorr B, Matz J, Bernstein JAet al. Montelukast for chronic asthma in 6 to 14-year-old children: a randomized double blind trial.JAMA 1998; 279: 1181–1186.

    Article  PubMed  CAS  Google Scholar 

  15. Knorr B, Luis M, Bisgaard Het al. Montelukast, a leukotriene receptor antagonist for the treatment of persistent asthma in children aged 2–5 years.Pediatrics 2001; 108(3): 1–10.

    Article  Google Scholar 

  16. Bisgaard H, Nielson KG. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children.Am J Respir Crit Care Med 2000; 161: 1–4.

    Google Scholar 

  17. Bisgaard H, Gilles J, Groenwald Met al. The effect of inhaled fluticasone proprionate in the treatment of young asthmatic children.Am J Respir Crit Care Med 1999; 160: 126–131.

    PubMed  CAS  Google Scholar 

  18. Kemp JP, Skoner DP, Szefler SJet al. Once daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.Ann Allergy Asthma Immunol 1999; 83: 231–239.

    Article  PubMed  CAS  Google Scholar 

  19. Tinkelman DG, Reed CE, Nelson HSet al. Aerosol beclomethasone diproprionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children.Pediatrics 1993; 92: 64–77.

    PubMed  CAS  Google Scholar 

  20. Shapiro GG, Koning P. Cromolyn sodium: a review.Pharmacotherapy 1985; 5 : 156–170.

    PubMed  CAS  Google Scholar 

  21. Edelman JM, Preston SR, Turpin JRet al. Parent and child preference for montelukast, a leukotriene receptor antagonist compared to inhaled cromolyn in asthmatic children aged 6 to 11 years.Eur Respir J 1998; 12(Suppl 29): 18S.

    Google Scholar 

  22. Wowciechowska I, Duenas-Meza E, Kosa Let al. Compliance and preference of montelukast vs. cromolyn in children with asthma.Allergy 1999; 54(Suppl): 25

    Article  Google Scholar 

  23. Nguyen H, Zhang J, Larson Pet al. Use of population one compartment model to design a study to best estimate AUC with limited number of time points per patient.Clin Pharm Ther 1998; 63: 191.

    Google Scholar 

  24. Knorr B, Noonan G, McBurney Jet al. Evaluation of long term effect of montelukast in adult (>15 years) and pediatric (6–14 years) patients.Eur Respir J 1999; 14(suppl): 290S.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Shanti Mukund Hospital, New Delhi

    Sham Kukreja, S. Sanjay, Gautam Ghosh, K. K. Aggarwal & Ashok Moharana

  2. Consultant Child Specialist, Hyderabad

    S. Sanjay

  3. Childhood Asthma Clinic, Kolkata

    Gautam Ghosh

  4. Consultant Pediatrician, New Delhi

    K. K. Aggarwal

  5. Ranbaxy Laboratories Pvt. Ltd., New Delhi, India

    Ashok Moharana

Authors
  1. Sham Kukreja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Sanjay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gautam Ghosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. K. Aggarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ashok Moharana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashok Moharana.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kukreja, S., Sanjay, S., Ghosh, G. et al. Montelukast — evaluation in 6 to 14 years old children with persistent asthma — pediatric montelukast study group. Indian J Pediatr 71, 811–815 (2004). https://doi.org/10.1007/BF02730720

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02730720

Key words

Search

Navigation